U.S. government shuts down Impact on NCI uncertain as administration threatens more RIFs

OMB’s plan to increase political control of science faces stiff opposition on Capitol Hill

The Trump administration has a fight on its hands as it pushes forward with a plan to exert greater political control over government funding of science.

July 10, 2026

Vol.52 No.27

By Paul Goldberg

The long life of a clinical trial
How JCO sustains landmark oncology research

In modern oncology, important insights from clinical trials often emerge years after initial publication. As new therapies extend survival and transition more patients into long-term remissions, clinicians and researchers are increasingly looking beyond initial response rates to understand durability, long-term safety, and even the possibility of a cure.

July 10, 2026

Vol.52 No.27

By Journal of Clinical Oncology

In Brief

Ned Sharpless’s portrait unveiled at FNIH ceremony

Former NCI director Norman “Ned” Sharpless had his portrait unveiled at a ceremony hosted by the Foundation for the National Institutes of Health on the main NIH campus in Bethesda.

July 10, 2026

Vol.52 No.27

Cancer Policy

AACR urges OMB to retract proposed rule on federally funded research

The American Association for Cancer Research is urging the White House Office of Management and Budget to rescind its recent proposed rule that would give the administration unprecedented political control over government-funded science.

July 02, 2026

Vol.52 No.26

By Sara Willa Ernst

Podcast The Directors

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions”

How’s this for a paradox: The better cancer centers become at keeping patients alive, the more expensive cancer care becomes. This brutal tradeoff hits harder in rural areas, where the cancer burden is higher and the investigator and clinical trial representation is lower.

June 26, 2026

Vol.52 No.25

By Paul Goldberg and Claire Marie Porter

Cancer Policy

OMB draft rule politicizing research should be rescinded, House Dems urge in a letter to Bhattacharya

Democratic leaders of the House Committee on Energy and Commerce are urging NIH Director Jay Bhattacharya to voice objections to a proposed rule from the Office of Management and Budget that would give the administration unprecedented political control over government-funded science.

June 26, 2026

Vol.52 No.25

By Jacquelyn Cobb

U.S. government shuts down

Impact on NCI uncertain as administration threatens more RIFs

YOU MAY BE INTERESTED IN

OMB’s plan to increase political control of science faces stiff opposition on Capitol Hill

The long life of a clinical trial
How JCO sustains landmark oncology research

Ned Sharpless’s portrait unveiled at FNIH ceremony

AACR urges OMB to retract proposed rule on federally funded research

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions”

OMB draft rule politicizing research should be rescinded, House Dems urge in a letter to Bhattacharya

Renew today!

Subscriber content

Never miss an issue!

Login

U.S. government shuts down

Impact on NCI uncertain as administration threatens more RIFs

YOU MAY BE INTERESTED IN

OMB’s plan to increase political control of science faces stiff opposition on Capitol Hill

The long life of a clinical trialHow JCO sustains landmark oncology research

Ned Sharpless’s portrait unveiled at FNIH ceremony

AACR urges OMB to retract proposed rule on federally funded research

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas“Institutions are feeling crunched in so many different directions”

OMB draft rule politicizing research should be rescinded, House Dems urge in a letter to Bhattacharya

Never miss an issue!

Login

The long life of a clinical trial
How JCO sustains landmark oncology research

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions”